ProMIS Neurosciences has reported six-month interim safety and biomarker data [...]

The EMA’s CHMP has recommended approval of NEZGLYAL for boys [...]

Rutgers researchers found that changes in brain network dynamics were [...]

Natus has expanded access to its AI-powered EEG analysis tool [...]

Alto Neuroscience has raised $100 million through an underwritten registered [...]

New Phase 1 data show Vandria’s VNA-318 reaches the human [...]

CONNECTA Therapeutics will present preclinical data supporting its Phase 2a [...]

GlobalData has identified Takeda’s oveporexton FDA decision as one of [...]

Al-S Pharma reports Phase 2 AP-101 data in ALS showing [...]

TRIMTECH Therapeutics has secured an additional $14 million in seed [...]